124 related articles for article (PubMed ID: 38702883)
1. Parkinson's disease-associated mutations in α-synuclein alters its lipid-bound state.
Maltseva S; Kerr D; Turke M; Adams EJ; Lee KYC
Biophys J; 2024 May; ():. PubMed ID: 38702883
[TBL] [Abstract][Full Text] [Related]
2. Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
Stefanovic AN; Lindhoud S; Semerdzhiev SA; Claessens MM; Subramaniam V
Biochemistry; 2015 May; 54(20):3142-50. PubMed ID: 25909158
[TBL] [Abstract][Full Text] [Related]
3. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.
Ruf VC; Nübling GS; Willikens S; Shi S; Schmidt F; Levin J; Bötzel K; Kamp F; Giese A
ACS Chem Neurosci; 2019 Mar; 10(3):1649-1659. PubMed ID: 30605594
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein.
Guan Y; Zhao X; Liu F; Yan S; Wang Y; Du C; Cui X; Li R; Zhang CX
Front Cell Neurosci; 2020; 14():159. PubMed ID: 32595456
[TBL] [Abstract][Full Text] [Related]
5. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.
Lima VA; do Nascimento LA; Eliezer D; Follmer C
ACS Chem Neurosci; 2019 Jan; 10(1):690-703. PubMed ID: 30352158
[TBL] [Abstract][Full Text] [Related]
6. Change in the Oligomeric State of α-Synuclein Variants in Living Cells.
Fan HF; Chen WL; Chen YZ; Huang JW; Shen YX
ACS Chem Neurosci; 2022 Apr; 13(8):1143-1164. PubMed ID: 35394271
[TBL] [Abstract][Full Text] [Related]
7. Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants.
Watt KJC; Meade RM; Williams RJ; Mason JM
J Biol Chem; 2022 Dec; 298(12):102565. PubMed ID: 36208776
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-terminal Acetylation on the Aggregation of Disease-related α-synuclein Variants.
Bell R; Castellana-Cruz M; Nene A; Thrush RJ; Xu CK; Kumita JR; Vendruscolo M
J Mol Biol; 2023 Jan; 435(1):167825. PubMed ID: 36099961
[TBL] [Abstract][Full Text] [Related]
9. Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation.
Xu B; Fan F; Liu Y; Liu Y; Zhou L; Yu H
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238596
[TBL] [Abstract][Full Text] [Related]
10. Combination of liquid crystal and deep learning reveals distinct signatures of Parkinson's disease-related wild-type α-synuclein and six pathogenic mutants.
Yang X; Zhao X; Zhao H; Liu F; Zhang S; Zhang CX; Yang Z
Chem Asian J; 2022 Jan; 17(2):e202101251. PubMed ID: 34877798
[TBL] [Abstract][Full Text] [Related]
11. Missense Mutations Modify the Conformational Ensemble of the
Guzzo A; Delarue P; Rojas A; Nicolaï A; Maisuradze GG; Senet P
Front Mol Biosci; 2021; 8():786123. PubMed ID: 34912851
[No Abstract] [Full Text] [Related]
12. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
[TBL] [Abstract][Full Text] [Related]
13. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
Rutherford NJ; Moore BD; Golde TE; Giasson BI
J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein and familial variants affect the chain order and the thermotropic phase behavior of anionic lipid vesicles.
Pantusa M; Vad B; Lillelund O; Kjær L; Otzen D; Bartucci R
Biochim Biophys Acta; 2016 Sep; 1864(9):1206-1214. PubMed ID: 27177693
[TBL] [Abstract][Full Text] [Related]
15. Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity.
Sanjeev A; Mattaparthi VSK
J Biomol Struct Dyn; 2018 Jul; 36(9):2224-2236. PubMed ID: 28650719
[TBL] [Abstract][Full Text] [Related]
16. Fibrillation of α-synuclein triggered by bacterial endotoxin and lipid vesicles is modulated by N-terminal acetylation and familial Parkinson's disease mutations.
Monteiro Neto JR; Lima VA; Follmer C
FEBS J; 2024 Mar; 291(6):1151-1167. PubMed ID: 38069536
[TBL] [Abstract][Full Text] [Related]
17. Wild-Type
Guzzo A; Delarue P; Rojas A; Nicolaï A; Maisuradze GG; Senet P
Front Mol Biosci; 2022; 9():910104. PubMed ID: 35836937
[No Abstract] [Full Text] [Related]
18. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.
Sakai R; Suzuki M; Ueyama M; Takeuchi T; Minakawa EN; Hayakawa H; Baba K; Mochizuki H; Nagai Y
PLoS One; 2019; 14(6):e0218261. PubMed ID: 31242217
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Alpha-Synuclein and Its Mutants with Rigid Lipid Vesicle Mimics of Varying Surface Curvature.
McClain SM; Ojoawo AM; Lin W; Rienstra CM; Murphy CJ
ACS Nano; 2020 Aug; 14(8):10153-10167. PubMed ID: 32672441
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein-induced tubule formation in lipid bilayers.
Pandey AP; Haque F; Rochet JC; Hovis JS
J Phys Chem B; 2011 May; 115(19):5886-93. PubMed ID: 21520980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
